SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed on August 11, 2020, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The filing serves to announce the Company's financial results for the three and six months ended June 30, 2020. The detailed results are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K filing.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. It only confirms that results for the periods ended June 30, 2020, have been issued.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the three and six months ended June 30, 2020, by reviewing Exhibit 99.1 (the attached press release).
- Confirm the Company's cash position and liquidity status as detailed in the full financial results.
- Review the press release for any updated guidance or commentary on the impact of the COVID-19 pandemic on operations.
- Note that the registrant is Ra Medical Systems, Inc., trading under the symbol RMED on the NYSE.